A fuller and more comprehensive understanding can help us search for SIRT1 modulators with high bioavailability and specificity and provide new efficient targets for the treatment and management of endocrine and metabolic diseases, such as PCOS. The gene discussed is SIRT1; the disease is polycystic ovary syndrome.